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ABSTRACT  
   
The presence of compounds such as pharmaceuticals and personal care 
products (PPCPs) in the environment is a cause for concern as they exhibit 
secondary effects on non-target organisms and are also indicative of incomplete 
removal by wastewater treatment plants (WWTPs) during water reclamation. 
Analytical methods and predictive models can help inform on the rates at which 
these contaminants enter the environment via biosolids use or wastewater effluent 
release to estimate the risk of adverse effects. The goals of this research project 
were to integrate the results obtained from the two different methods of risk 
assessment, (a) in silico modeling and (b) experimental analysis.  
Using a previously published empirical model, influent and effluent 
concentration ranges were predicted for 10 sterols and validated with peer-
reviewed literature. The in silico risk assessment analysis performed for sterols 
and hormones in biosolids concluded that hormones possess high leaching 
potentials and that particularly 17-α-ethinyl estradiol (EE2) can pose significant 
threat to fathead minnows (P. promelas) via leaching from terrestrial depositions 
of biosolids.  
Six mega-composite biosolids samples representative of 94 WWTPs were 
analyzed for a suite of 120 PPCPs using the extended U.S. EPA Method 1694 
protocol. Results indicated the presence of 26 previously unmonitored PPCPs in 
the samples with estimated annual release rates of 5-15 tons yr
-1
 via land 
application of biosolids. A mesocosm sampling analysis that was included in the 
study concluded that four compounds amitriptyline, paroxetine, propranolol and 
  ii 
sertraline warrant further monitoring due to their high release rates from land 
applied biosolids and their calculated extended half-lives in soils.  
There is a growing interest in the scientific community towards the 
development of new analytical protocols for analyzing solid matrices such as 
biosolids for the presence of PPCPs and other established and emerging 
contaminants of concern. The two studies presented here are timely and an 
important addition to the increasing base of scientific articles regarding 
environmental release of PPCPs and exposure risks associated with biosolids land 
application. This research study emphasizes the need for coupling experimental 
results with predictive analytical modeling output in order to more fully assess the 
risks posed by compounds detected in biosolids. 
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PREFACE 
 As an independent project, a modeling analysis was performed using input 
data from the 2007 Targeted National Sewage Sludge Survey conducted by the7 
U.S. Environmental Protection Agency (EPA). This in silico study utilized two 
empirical models that were derived independently. Obtained results from 
modeling of aqueous phase concentration ranges of anthropogenic organic 
compounds were organized in the form of a scientific paper and submitted to the 
peer-reviewed journal Science of The Total Environment in response to the 
editor’s invitation to participate in the 2nd Annual SCARCE Special Issue. The 
paper is currently under review for publication. The findings have been included 
in the present research study under Chapter II. 
 In the month of August (2011), archived samples of municipal sewage 
sludge deemed fit for application on land (biosolids) and originally acquired by 
the U.S. EPA as part of the 2001 Targeted National Sewage Sludge Survey were 
re-analyzed using a mega-composite analysis approach and a new analytical 
protocol representing an expanded version of U.S. EPA Method 1694 (The new 
protocol currently is termed AXYS MLA-075). The results obtained were 
compiled and were used to report on newly detected organic trace contaminants in 
biosolids and to evaluate the reliability of national data generated using the mega 
composite sampling approach. In addition to the mega-composite sample analysis, 
archived soil-biosolids mixtures that were obtained as part of an outdoor 
mesocosm study conducted in 2010 were analyzed using the same protocol. The 
results were used to calculate the experimental half-lives for compounds that were 
  xi 
sequestered in biosolids and inform on their extended half-lives in soils. Findings 
were organized into a scientific paper submitted in the month of March 2012 to 
the peer-reviewed journal Water Research. This paper is currently under review 
for publication and has been included in this thesis as Chapter III. 
 
 
 
 
Figure 1. Research study flow chart
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Chapter 1: INTRODUCTION 
1.1 LITERATURE REVIEW 
1.1.1 Wastewater treatment process 
 The National Stream Reconnaissance conducted during the years 1999 and 
2000 by the U.S Geological Survey (USGS) served to identify and quantify a 
wide range of emerging contaminants in U.S surface waters (Kolpin et al 2002). 
Follow-up work on the behavior of organic compounds (OCs) during wastewater 
treatment firmly established a range of theoretically biodegradable compounds 
that are only removed incompletely and remain detectable in both treated effluent 
and biosolids, i.e., treated sewage sludge deemed fit for application on land 
(Ingrand et al 2003; Lorenzen et al 2004; Ying and Kookana 2005; Cicek et al 
2007). When treated effluent and biosolids are used for beneficial purposes such 
as irrigation and soil amendment, there exists a threat of releasing the contained 
chemicals into the environment (Xia et al 2005; Kinney et al 2006; Wu et al 
2010).  
 The primary aim of a wastewater treatment plant (WWTP) is to treat 
municipal discharges such that they meet the recommended microbiological and 
chemical quality guidelines before effluent release or reuse. This is achieved 
using a combination of physical, chemical and biological processes to remove 
solids, nutrients and contaminants from wastewater producing the effluent and 
sewage sludge as by-product. However, in recent times conventional WWTPs 
have come under scrutiny due to ineffective treatment and subsequent release of a 
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wide variety of chemical compounds via effluent discharge and land application 
of sewage sludge or biosolids.  
 The behavior of organic compounds during wastewater treatment is 
difficult to characterize due to the diversity of chemical structures and the 
complexity of the processes involved. Within the WWTPs, the influent gets 
segregated and transformed into two distinct process flows, organic-rich biosolids 
and the liquid effluent. Compounds undergo preferential partitioning between the 
aqueous phase and the sludge primarily based on their hydrophobicity, which 
typically is gauged by examining their n-octanol-water partition coefficient (Kow)
 
(Kinney et al 2006; Heidler and Halden 2008). Whereas hydrophobic compounds 
having large KOW values (>10,000) partition almost completely into biosolids, 
compounds having lower KOW values (<10,000) typically are removed by a 
combination of biodegradation and sorption processes (Khanal et al 2006). Since 
one of these processes results in the transformation of a chemical’s mass 
(biodegradation) and the other merely implies a transfer of chemicals from the 
aqueous phase into the sorbed, solid phase, it is important to distinguish among 
the two when evaluating the fate of a chemical during municipal wastewater 
treatment.  
1.1.2 Biosolids 
 Following the release of PPCPs into the environment, a multitude of 
exposure pathways have been found to exist between the source and human 
beings. An increasing number of research articles show that land application of 
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materials that contain sequestered chemicals, such as biosolids and feather-meal 
fertilizer could serve as an important mechanism for chemical re-entry into the 
environment (Chari and Halden 2012b; Love et al 2012). Biosolids is the solid, 
semi-solid or liquid organic material obtained as a by-product of municipal 
wastewater treatment. Following the Ocean Dumping Ban Act of 1988, recycling 
biosolids via land application has become the major means of disposal. The 
increase in production has resulted in a corresponding increase in the amount of 
biosolids used for beneficial purposes, from 36% in 1988 to approximately 55% 
in 2007 (USEPA 1992; NEBRA 2007). In recent years however, biosolids have 
been proved to behave as reservoirs for pollutants and land application can release 
pollutants into groundwater and waterways through leaching and runoff (Kinney 
et al 2006; Gottschall et al 2012; Chari and Halden 2012a).  
1.1.3 Effluent dominated waters 
 An estimated 23% of WWTPs discharge effluents under conditions where 
instream dilution offered by the receiving waters is less than 10-fold. Depending 
on the season, the stream can be partially or fully dominated by the discharged 
effluent thus increasing the exposure to chemicals released via wastewater 
effluent discharge (Brooks et al 2003). Such a scenario occurs in perennial and 
ephemeral streams in arid and semi-arid regions around the world and especially 
the southwestern United States (Mladenov et al 2005; Brooks et al 2006). Study 
of aquatic ecosystems that are supported in part or completely by effluent flow is 
gaining interest owing to certain unique water quality characteristics inherent to 
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such streams and the ecotoxicological properties of the compounds released into 
the environment (Taylor 2002). One class of compounds that have long been 
scrutinized with regards to their occurrence in surface waters are phytosterols. 
Phytosterols occur naturally in the environment and also are major constituents of 
pulp and paper mill effluents. Sterol mixtures are known to be capable of inducing 
sexual and morphological changes in aquatic organisms (Nakari et al 2003; 
Honkanen et al 2004; Lopez et al 2011), and a large volume of literature shows 
that the products of microbially mediated breakdown of phytosterols, such as 
androstenedione and steroid hormones, possess endocrine disrupting properties at 
the ng/L range (Jenkins et al 2003; Orrego et al 2009).  
1.1.4 Leaching potential of compounds 
 There have been several lab-scale and field-scale studies conducted that 
evaluate the leaching potential of compounds from land-applied biosolids to 
surface waters and groundwater. Although largely confined to pharmaceuticals 
and personal care products (PPCPs), studies conducted by Lapen et al (2008), 
Topp et al (2008) and Edwards et al (2009) confirmed that biosolids can act as a 
non-point sources of water contamination when sorbed compounds migrate from 
the site of application to tile drainage systems and eventually to surface waters. 
Key parameters that were identified to influence the transport of compounds from 
biosolids-amended fields were macroporous structures in the soil, soil texture, 
composition and moisture of the biosolids, and the method of biosolids 
application (e.g., surface spreading of solids vs. injection of the materials as a 
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slurry). A recent field study confirmed that hormones in land-applied biosolids are 
mobilized following strong rainfall events and that the total estrogen 
concentration in runoff exceeded thresholds for biological effects for time periods 
of >30 days post application (Yang et al 2012). The authors also stated that 35 
days after application, biosolids-borne hormones were still detectable in the soil 
and did not complete degrade.  
1.1.5 Targeted National Sewage Sludge Survey (TNSSS) 
 The TNSSS study and previous national sewage sludge surveys were 
conducted by the U.S Environmental Protection Agency (USEPA) under 
provisions of the Clean Water Act (CWA) to provide national estimates of 
compounds present in biosolids and their respective concentrations. Historically, 
biosolids have been analyzed for pathogens, heavy metals, poly aromatic 
hydrocarbons (PAHs), polychlorinated biphenyls (PCBs) and polychlorinated 
dibenzo-p-dioxins (PCDDs) as well as emerging contaminants, with an increasing 
focus on pharmaceuticals, sterols and hormones. Results from the first survey 
conducted in 1988 helped establish the Part 503 Biosolids Use and Disposal 
Regulations that led to a source reduction of dioxins and furans (USEPA 2002). 
The second study conducted in 2001 served to evaluate the reduced occurrences 
of dioxins and dioxin-like compounds in sludge samples (USEPA 2007). The 
most recent survey carried out in 2007 evaluated the occurrences of 
pharmaceuticals and personal care products (PPCPs) in 84 biosolids samples that 
were representative of 3,337 WWTPs across the nation. Seventy-two PPCPs and 
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25 steroids and hormones were detected in concentrations ranging from the parts-
per-billion (ppb) to the parts-per-million (ppm) range by using USEPA Method 
1694 (USEPA 2007). 
 As a part of TNSSS 2007 study and other CWA programs, the U.S. EPA 
developed and released an analytical protocol, EPA Method 1694. This protocol 
was originally designed to determine the concentration of 73 PPCPs in multi-
media environmental samples by high performance liquid chromatography 
combined with tandem mass spectrometry (HPLC-MS/MS). It was based on 
analytical methods developed previously and those existing at the time and 
procedures developed at AXYS Analytical Services, a Canadian commercial 
laboratory. The analytical range of this protocol recently was expanded by AXYS 
to include a total of 120 PPCPs and the new, extended Method 1694 referred to as 
MLA-075 was used in the present study to analyze biosolids samples.  
1.1.6 Mesocosm study 
 In 2005, a mesocosm study was conducted in Baltimore, Maryland to 
experimentally determine the half-lives of compounds sequestered in biosolids 
that are land-applied. The study was conducted under ambient outdoor conditions 
with no shelter or artificial irrigation. Biosolids and soil were mixed in the ratio 
2:1 to facilitate detection of compounds three years after commencement. Six 
plastic containers were used of approximate dimensions of 30-80 x 30 x 25 cm 
featuring perforated bottoms to allow drainage of excess water. The leachate 
water was not included in the analysis. Containers filled with 100% soil showing 
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no background levels of PPCPs served as controls. Samples taken on the 57
th
, 
115
th
, 520
th
, 859
th
 and 995
th
 day were analyzed for a suite of 120 PPCPs using the 
AXYS Method MLA - 075. Following a previous study conducted on the same 
samples by Walters et al. (2010), empirical half-lives were calculated by fitting 
the data to a first-order kinetics equation. 
 
1.2 SCOPE OF STUDY 
This research study is presented as  
(i.) Study I, mega composite sampling approach undertaken to analyze 
archived biosolids samples for a suite of 120 PPCPs using the extended 
USEPA Method 1694, and  
(ii.) Study II, modeling study undertaken to predict the aqueous phase 
concentrations for organic compounds in wastewater dominated streams 
and in run-off from biosolids amended soils.   
 The following chapters detail two original studies that I carried out related 
to biosolids and the TNSSS studies conducted by the U.S. EPA. The first study 
detailed in Chapter II describes the in silico approach undertaken to (i) identify 
potentially problematic organic compounds in biosolids, (ii) predict influent and 
effluent levels for hydrophobic organic compounds (HOCs) of emerging concern, 
and (iii) provide initial estimates of runoff concentrations, in this case four 
prominent hormones known to act as endocrine disruptors.  
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 Chapter III details the second study, wherein mega-composite samples 
were constructed with archived biosolids samples and analyzed along with soil-
biosolids mesocosm study samples using the extended U.S. EPA Method 1694. 
The results revealed (i) 26 previously non-reported compounds that were detected 
in ppb concentrations, (ii) the corresponding first estimates of nationwide release 
rates of these previously non-monitored compounds to soils, and (iii) estimates of 
half-lives of select compounds in soils amended with biosolids.  
 .  
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Chapter 2: STUDY I 
MODELING STUDY UNDERTAKEN TO PREDICT THE AQUEOUS PHASE 
CONCENTRATIONS FOR ORGANIC COMPOUNDS IN WASTEWATER 
DOMINATED STREAMS AND IN RUN-OFF FROM BIOSOLIDS AMENDED 
SOILS 
2.1 INTRODUCTION 
 In the present study a validated empirical model leveraging mass balance 
approaches and partitioning theory (Deo and Halden 2009) was used to model the 
aqueous concentrations of 10 sterols based on their reported biosolids 
concentrations. The model was originally introduced as a screening tool to 
identify potentially problematic sewage constituents and to predict the behavior 
and extent of partitioning a given compound is likely to undergo during treatment 
in a real-world POTW (Heidler and Halden 2008; Deo and Halden 2010). The 
sole parameters required for operation of the model are the compound’s 
concentration in biosolids (Cbiosolids), its pH-adjusted n-octanol/water partitioning 
coefficient (DOW) and a dimensionless curve-fitting parameter (pfit) (Deo and 
Halden 2009; Weir et al 2010). Thus far, the model has been applied only to 
compounds within a limited range of log DOW values of 4.9 – 6.4. The present 
study intended to expand the applicability of the model and to validate its 
performance using data available in the peer-reviewed literature.  
10 
 
 A secondary objective of this paper was to also consider the potential for 
runoff and leaching of chemicals following application of biosolids on land for 
inexpensive disposal and for soil conditioning and fertilization.  Langdon et al 
(2010) further utilized another model to estimate the toxicity posed by natural and 
synthetic hormones contained in biosolids using pore-water concentrations 
(Cporewater) as model input. This model adopted an equilibrium-based partitioning 
approach that required Cbiosolids and KOW as primary input parameters in addition 
to general parameters discussed hereafter. In the present work, both models were 
combined to estimate the concentration in influent and effluent (Cinf and Ceff, 
respectively) for 10 sterols, and the run-off potential for four hormones that have 
been frequently reported in literature, estrone (E1), estradiol (E2), estriol (E3) and 
17-β-ethinylestradiol (EE2). 
11 
 
2.2  EXPERIMENTAL METHODS 
Aqueous phase concentrations were calculated for 14 hydrophobic organic 
compounds (HOCs) based on their Cbiosolids, log DOW and log KOW values using 
two independent models.  
2.2.1 EMPIRICAL MODEL I  
The fraction of the total mass of a given compound entering a POTW (fbiosolids) 
was calculated using an established empirical model (Eq. 1) that previously had 
been validated for application in the log DOW range of 4.9 – 6.4 (Deo and Halden, 
2010). Prior studies also had identified a value of 1.76 x 10
-6
 as appropriate for 
the dimensionless fitting parameter, pfit. 
   (Eq. 1) 
Using mass-balance approaches, the concentration of a chemical in biosolids, 
Cbiosolids can be determined as a function of the total concentration of the chemical 
entering the POTW, Cinfluent, the fraction amenable to sequestration in biosolids 
(fbiosolids) and the yield of biosolids per volume of raw wastewater treated (Y). 
 (Eq. 2) 
The value of Y was taken from the literature, 2.4 x 10
-4 
kg/L (Kinney et al., 2006). 
Eq. 2 was rearranged as shown in Eq. 3 to yield influent concentrations.  
  (Eq. 3)   
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At any time, the relation between total mass of the compound leaving a POTW, 
Ceffluent is dependent on its Cinfluent and Cbiosolids,values can be expressed as, 
 (Eq. 4)  
The above relationship was rearranged to include Eq. 3 that enabled calculation of 
the effluent concentration (Ceffluent). 
 (Eq. 5) 
The removal efficiency of individual compounds and the model’s accuracy was 
validated using the most recent results obtained from a study conducted on the 
removal of sterols in POTWs in Canada (Furtula et al., 2011). Removal 
efficiencies (Predicted vs. Observed) were matched for each compound by a 
paired t-test at the confidence level of p = 0.01. 
 
2.2.2 EMPIRICAL MODEL II 
The leaching potential of hormones was predicted based on Cbiosolids values 
reported in the recent Targeted National Sewage Sludge Survey (TNSSS) 
conducted by the U.S. EPA (USEPA 2009a). Model II was developed previously 
by another research group (Langdon et al 2010). It was specifically used for 
analyzing hormones, since these compounds are not as hydrophobic as the sterols, 
and previous models had a restrictive use with regards to compounds of low 
hydrophobicity. 
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The concentration of a given hormone in homogenized mixtures of soil and 
biosolids was calculated according to Eq. 4  
        (Eq. 4) 
, where Cbiosolids and Csoil represent the mass of biosolids and soil, respectively, that 
were mixed together during application. For moist soils, the partitioning of a 
given compound between the solid and aqueous phases was estimated using Eq. 5, 
               (Eq. 5) 
, where Mb is the mass in μg of the compound associated with the solid phase at 
equilibrium, and Msoln in units of μg is the mass of the compound present in the 
dissolved state in the aqueous phase at equilibrium. Representative values for soil 
density, Ms, of 1.3 g cm
-3
 and for soil moisture content, Vo, of 0.22% were taken 
from the literature (De Lannoy et al 2006). The soil:biosolids mixing ratio was 
assumed to equal 25:1 based on recommendations by the U.S. EPA (McClellan 
and Halden 2010).  
The pore-water concentration of a given compound at equilibrium was calculated 
using Eq. 6, 
            (Eq. 6) 
, where Cporewater is the concentration of a compound in saturated soil (μg/L) and 
Mo is the mass of compound in 1 cm
3
 of soil after equilibration (μg/1.3gm). 
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2.3 RESULTS 
2.3.1 VALIDATION OF EMPIRICAL MODEL I 
The present study served to expand the applicability of an existing empirical 
model and validate its output by comparing the predicted versus actual removal 
efficiencies (expressed in %) for the sterol compounds shown in Table 1. A paired 
t-test was performed for nine of the ten sterols considered here; ergosterol could 
not be included because the dataset by Furtula et al (2010) lacked information on 
this compound. Predicted values were found to match observed ones very closely, 
as indicated by a factor of 1.04 ± 0.04 that was very close to the ideal value of 
unity. Results from the t-test analysis confirmed the two datasets to be statistically 
indistinguishable at the 99% confidence interval.  
Table 1. List of sterols that were analyzed in this study. Cbiosolids (μg kg
-1
) values 
were taken from the TNSSS 2009 reports (U.S. EPA, 2009) and compound 
structures, log Dow (sterols) and log Kow (hormones) values and CAS numbers 
were taken from RSC online database and the literature (Ying et al., 2002). Half-
life values reported are for aquatic environments and were estimated using the 
PBT Profiler of the U.S. EPA. 
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Desmosterol 
log Dow: 9.27 
CAS: 313-04-2 
Cbiosolids: 2230 
(min)  
94,400 (max) 
14,816 (mean) 
t1/2: 60 days 
 
Ergosterol 
log Dow: 9.3 
CAS: 57-87-4 
Cbiosolids: 2180 
(min)  
91,900 (max) 
20,080 (mean) 
t1/2: 60 days 
 
Campesterol 
log Dow: 9.97 
CAS: 474-62-4 
Cbiosolids: 2840 
(min)  
524,000 (max) 
97,298 (mean) 
t1/2: 60 days 
 
Coprostanol        
log Dow: 10.06 
CAS: 360-68-9 
Cbiosolids: 7720 
(min)  
43,700,000 (max) 
2,795,254 (mean) 
t1/2: 60 days 
 
Cholestanol 
log Dow: 10.07 
CAS: 80-97-7 
Cbiosolids: 3860 
(min)  
4,590,000 (max) 
473,067 (mean) 
t1/2: 60 days 
 
Cholesterol 
log Dow: 9.62 
CAS: 57-88-5 
Cbiosolids: 2,340 
(min)  
5,390,000 (max) 
727,338 (mean) 
t1/2: 60 days 
 
Epicoprostanol 
log Dow: 10.06 
CAS: 516-92-7 
Cbiosolids: 868 (min)  
6,030,000 (max) 
818,673 (mean) 
t1/2: 60 days 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stigmasterol 
log Dow: 10.07 
CAS: 83-48-7 
Cbiosolids: 455 (min)  
806,000 (max) 
120,671 (mean) 
t1/2: 60 days 
β-Stigmastanol 
log Dow: 10.07 
CAS: 83-45-4 
Cbiosolids: 3440 (min)  
1,330,000 (max) 
152,834 (mean) 
t1/2: 60 days 
β-Sitosterol 
log Dow: 10.73 
CAS: 83-46-5 
Cbiosolids: 1210 (min)  
1,640,000 (max) 
302,123 (mean) 
t1/2: 60 days 
Estrone (E1) 
log Kow: 3.43 
CAS: 53-16-7 
Cbiosolids: 19.70 (min)  
965 (max) 
109.34 (mean) 
t1/2: 38 days 
17-β-Estradiol (E2) 
log Kow: 3.94 
CAS: 50-28-2 
Cbiosolids: 16.20 (min)  
355 (max) 
35.57 (mean) 
t1/2: 38 days 
Estriol (E3) 
log Kow: 2.81 
CAS: 50-27-1 
Cbiosolids: 5.80 (min)  
232 (max) 
38.85 (mean) 
t1/2: 38 days 
17-α-
Ethinylestradiol 
(EE2) 
log Kow: 4.15 
CAS: 57-91-0 
Cbiosolids: 12.80 (min)  
61.90 (max) 
22.53 (mean) 
t1/2: 38 days 
Androstenedione 
log Kow: 2.75 
CAS: 63-05-8 
Cbiosolids: 57.70 (min)  
1520 (max) 
328.44 (mean) 
t1/2: 60 days 
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2.3.2 MODELED CINF AND CEFF VALUES 
Modeling results for aqueous phase concentrations are shown in Figure 1. For a 
comparative analysis, the concentrations were plotted as logarithmic equivalents 
of the obtained values.  
17 
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Figure 2. Predicted concentration ranges of 10 steroids, plotted on a logarithmic 
scale, in POTW influent (Cinf) and effluent (Ceff), calculated based on 
concentrations in biosolids (Cbiosolids) reported in the peer-reviewed literature. 
Values that exceed or fall below the upper and lower quartiles by 1.5x appear as 
outlier symbols marked with the asterisk symbol (*). The greatest and smallest 
values excluding the outliers are denoted by the whiskers, whereas the box is 
delineated by the upper quartile (top of box), lower quartile (bottom of box) and 
the median value (center line). 
The top panel shows concentrations estimated for raw sewage entering the 
POTWs. The middle panel shows the model input values, i.e., the concentrations 
of analytes in biosolids on a dry weight basis. The bottom panel of Figure 1 shows 
the range of effluent concentrations returned by the model. An examination of the 
top and bottom panels of Figure 1and the information presented in Table 2 reveals 
that the predicted removal efficiencies for all sterols were uniformly high at 
99.9% and thus were in good agreement with those (86.4 to 99.1%) determined 
experimentally by Furtula et al (2011). Similarly, values reported by the U.S. EPA 
for Cinf and Ceff detected at POTWs (USEPA 2009b) were of the same magnitude 
as those predicted here and depicted in Figure 1.  
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Table 2. Modeled influent, effluent concentrations and removal efficiency for 10 
sterols. Removals calculated at POTWs were obtained from Furtula et al (2011) 
Compound 
 
 
Concentration in influent  (ng L-1) 
 
 
Concentration in effluent 
(ng L-1) 
 
%  
Removal 
Predicted 
 
% 
Removal 
Observed Cinfluent (Min) Cinfluent 
(Max) 
Cinfluent  
(Mean) 
Ceff.  
(Min) 
Ceff.  
(Max) 
Ceff.  
(Mean) 
Desmosterol 5.35E+02 2.27E+04 3.56E+03 0.163 6.9 1.1 99.9 93.1 
Ergosterol 5.23E+02 2.21E+04 4.82E+03 0.149 6.3 1.4 99.9 - 
Cholesterol 5.62E+02 1.29E+06 1.75E+05 0.077 176.3 23.8 99.9 98.7 
Campesterol 6.82E+02 1.26E+05 2.34E+04 0.041 7.7 1.4 99.9 98 
Coprostanol 1.85E+03 1.05E+07 6.71E+05 0.092 519 33.2 99.9 99.1 
Epicoprostanol 2.08E+02 7.82E+05 1.06E+05 0.01 71.6 9.7 99.9 94.3 
β-Stigmastanol 8.26E+02 3.19E+05 3.67E+04 0.04 15.4 1.8 99.9 96.7 
Cholestanol 9.26E+02 1.10E+06 1.14E+05 0.045 53.3 5.5 99.9 98.7 
Stigmasterol 1.09E+02 1.93E+05 2.90E+04 0.005 9.4 1.4 99.9 86.4 
β-Sitosterol 2.90E+02 3.94E+05 7.25E+04 0.003 4.2 0.8 99.9 97.7 
 
2.3.3 MODELED CPOREWATER VALUES 
Porewater concentrations (shown in Table 3) indicate the migration potential of 
compounds applied on soils in biosolids. Chemicals present in porewater are 
available for leaching into ground and surface water during rainfall events. 
Modeled Cporewater values for hormones, shown in Table 3, were in the parts-per-
trillion range, owing to the low Cbiosolids values.  
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Table 3. Modeled porewater concentrations for four hormones. 
Compound 
Cporewater  
(ng L
-1
)
 
Minimum 
Cporewater  
(ng L
-1
) 
Maximum 
Cporewater  
(ng L
-1
) 
Mean 
Aquatic 
toxicity  
(ng L
-1
) 
Estrone (E1) 0.00 55.14 5.80 15
a
; 50
b
 
17-β-Estradiol (E2) 0.49 10.71 1.07 5c 
Estriol (E3) 0.00 28.82 4.60 10
e
 
17-α-Ethinylestradiol (EE2) 0.00 0.70 0.55 0.32d 
Androstenedione* 0.00 204 41 - 
* Androstenedione is an androgen that was selected for modeling purposes only.  
a. Increased aggressiveness of fathead minnows (P. promelas) as seen during a 21-day study by 
Dammann et al (2011). 
b. Diminished egg production in P. promelas
 
as seen during a 21-day study by Dammann et al 
(2011). 
c. Caused vitellogenin induction in adult male Zebra fish (D. rerio) as reported by Brion et al 
(2004). 
d. Decreased male sex characteristics and reduced egg fertilization success observed in adult male 
P. promelas were reported by Parrott and Blunt (2004). 
e. Altered sex ratio seen in Japanese Medaka fish (O. latipes) as reported by Metcalfe et al (2001). 
In order to assess the hazard posed to aquatic organisms by the flushable mass 
fraction of compounds present in the aqueous phase (i.e., porewater), toxicity 
values taken from the literature were plotted alongside modeled values.  
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Figure 3. Predicted Cporewater range based on Cbiosolids values for 4 hormones. 
Circles represent aquatic toxicity threshold values that were reported in literature. 
As can be seen in Figure 2, the expected range of porewater concentrations of all 
4 analytes considered bracketed the toxicity values for sensitive aquatic species 
including fathead minnows (P. promelas) (Dammann et al 2011), Zebra fish (D. 
rerio) (Brion et al 2004) and Japanese Medaka fish (O. latipes) (Metcalfe et al 
2001). Additional information on calculated minima, means and maxima is 
presented in Table 3 along with specific information on observed adverse 
outcomes (Table 3, footnotes). 
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2.4 DISCUSSION 
2.4.1 STEROLS 
As shown in Table 2, the predicted removal efficiencies for all sterols were >99% 
which resulted in the extremely low concentrations in the effluent (Figure 2). 
These predictions matched closely the empirical removal efficiencies observed at 
treatment plants, as reported by Furtula et al (2010). Of the compounds that were 
analyzed, four were grouped as phytosterols (campesterol, β-sitosterol, 
stigmasterol and β-stigmastanol), five were associated with cholesterol as either 
precursors or breakdown products (cholesterol, desmosterol, cholestanol, 
coprostanol and epicoprostanol), and one was a fungal cell-wall component 
(ergosterol).  
Phytosterols are naturally occurring compounds that are known to be present in 
high concentrations in paper mill effluents and have been detected at the parts-
per-billion range downstream of rivers receiving effluent from mills. These 
compounds have been linked to androgenic effects in aquatic organisms caused 
either directly or as breakdown products of the parental sterols
 
(Ellis et al 2003; 
Jenkins et al 2003; Orrego et al 2009). Similar to phytosterols, cholesterol and 
related compounds have long been suspected of causing androgenic effects or 
giving rise to compounds that have androgenic effects (Ellis et al 2003; Jenkins et 
al 2003). More specifically, androstenedione, a microbial transformation product 
of phytosterols and cholesterol, is a known androgen (Jenkins et al 2004). In the 
present study, androstenedione (not presented in Fig. 2) was found to have highest 
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runoff potential among the hormones analyzed, owing to its low hydrophobicity 
(log KOW = 2.75) (See Table 1, Table 3). The Cporewater value calculated for 
androstenedione was 204 ng L
-1
 and nearly four times greater than that of the 
hormone estrone (E1), which had the highest migration potential amongst the four 
hormones analyzed. Considering that both phytosterols and cholesterol related 
compounds were detected in mg kg
-1
 range, the concentration of androstenedione 
that could migrate/leach to aqueous phase could be potentially higher than the 
values reported here. EPA’s PBT Profiler software suggests aquatic half-life 
values for the sterols considered here on the order of 60 days (Table 1).  
2.4.2 HORMONES 
A recent study ranked hormones among the most studied compounds with regards 
to their presence in the environment, and the compounds estrone (E1) and 17-β-
estradiol (E2) being the most thoroughly investigated (Miège et al 2009). The list 
of hormones analyzed in this study comprises both naturally occurring (E1, E2, 
E3) and synthetic (EE2) ones. While E1, E2 and E3 are excreted by humans 
naturally, EE2 is excreted only by women taking contraceptive pills. All of these 
hormones have been detected in the natural environment in the ppb range, 
especially in surface waters and all are known to cause a variety of secondary 
effects in aquatic organisms, including reversal of sex-ratios and delayed 
fertilization (Brion et al 2004; Parrott and Blunt 2004; Schäfers et al 2007; 
Dammann et al 2011). 
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While adequate details on the presence of E3 in the environment could not be 
gathered, the hazard posed by the remaining four hormones was assessed. The 
range of Cporewater predicted for E1, E2, E3 and EE2 was noted to encompass the 
values at which these compounds exert adverse effects on fathead minnows and 
zebra fish (see Table 3 and Figure 2). EE2 was found to have the smallest Lowest 
Observed Effect Concentration (LOEC) value amongst the hormones and was 
determined to possess the highest toxicity, whereas E1 was found to have the 
highest leaching potential, due to its relatively high concentration in biosolids and 
comparatively low hydrophobicity (log KOW 3.43). Yang et al (2012) suggested 
that both increased rainfall and increased hormone load applied in biosolids on 
land can trigger elevated runoff concentrations. The mass of hormones contained 
in runoff and leachate also is expected to vary based on the temporal precipitation 
profile, with intermittent rains potentially leading to the largest amount of mass 
released due to the extended equilibration time. However, the present model does 
not take into consideration variations in rainfall and assumes constant soil 
moisture content. 
2.4.3 ENVIRONMENTAL IMPLICATIONS 
The present study served to predict influent and effluent concentration ranges for 
10 sterols and investigate the implications of four hormones detected in biosolids 
samples as reported in the 2009 TNSSS study. The results presented in this study 
are representative of effluent discharges that receive little or no dilution via 
surface waters, and the here presented empirical model serves to function as a 
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screening tool that can be used to calculate the theoretical removal rates and the 
aqueous phase concentrations based on reported Cbiosolids values for compounds 
with log Dow values in the range of 4.9 to 10.  
Also calculated in this study were the migration potentials of four hormones 
included in the TNSSS. Modeled Cporewater values indicated that the migration 
potential of the hormones were in the descending order of E1>E3>E2>EE2; EE2 
was found to have a problematic hazard potential since the compound had the 
smallest LOEC value. The run-off predictions presented here and the order of 
migration potentials were found to agree with those presented by Yang et al. 
(2012). In conjunction with these results, a medaka assay conducted by Metcalfe 
et al (2001) revealed the relative estrogenic potentials of these four hormones 
were EE2>E2≈ E1>E3. Conventional POTWs are faced with the challenge of 
treating a continuous load of organic compounds, including phytosterols and 
hormones that possess endocrine disrupting properties. Findings from this study 
suggest that although sterols are removed from wastewaters at high efficiencies 
they tend to accumulate in biosolids, where they may be subject to microbial 
conversion to metabolites that possess relatively greater endocrine disrupting 
potential than the parent compounds. Compounds sequestered in biosolids and 
subsequently applied on land potentially can migrate into groundwater and 
surface waters and thus can pose a significant hazard to aquatic organisms, as 
shown by the results of this study. However, it is important to note that the mass 
fraction of compounds present in porewater is very small when compared to the 
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amount of chemical sorbed onto particles, and that equilibrium concentrations 
present in porewater will be diluted significantly during rainfall events. Thus, a 
hazard assessment based on equilibrium porewater concentrations has to be 
interpreted as a worst-case scenario. In reality, flushed porwater volumes will be 
diluted significantly by rainwater, thereby lowering due to dilution the risk of 
harmful exposures. Results of this modeling study suggest that although 
hydrophobic compounds readily partition into biosolids, they also are expected to 
be bioavailable at levels sufficiently high to cause endocrine disruption in 
sensitive aquatic species upon leaching from field soils amended with biosolids.  
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Chapter 3: STUDY II 
MEGA COMPOSITE SAMPLING APPROACH UNDERTAKEN TO 
ANALYZE ARCHIVED BIOSOLIDS SAMPLES FOR A SUITE OF 120 
PPCPS USING THE EXTENDED USEPA METHOD 1694 
3.1 INTRODUCTION 
The purpose of the present study was to examine the occurrence of previously 
unmonitored pharmaceuticals in archived biosolids samples and to critically 
evaluate the mega composite sampling approach that – for matters of 
convenience, speed and cost-effectiveness – relies on a very limited number of 
measurements to create estimates of national inventories of chemicals in 
biosolids, but whose reproducibility from an experimental perspective is as of yet 
unknown. Building on the list of 72 previously reported compounds (McClellan 
and Halden 2010), an additional 48 compounds were monitored in this work using 
a newly introduced analytical method (AXYS Method MLA-075) that extends the 
analyte range of U.S. EPA Method 1694 without changing any of the attributes 
inherent to the originally reported protocol. Study results reveal the identities of 
26 newly reported PPCPs in biosolids, yield U.S mass inventories for the latter, 
and provide evidence for the reproducible preparation and analysis of large 
biosolids composite samples constructed from 94 WWTPs across the U.S. 
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3.2 EXPERIMENTAL METHODS 
3.2.1 SAMPLING PROCEDURE 
This study utilized 113 biosolids samples obtained by the U.S. Environmental 
Protection Agency (EPA) for the 2001 National Sewage Sludge Survey (NSSS). 
These samples make up a small fraction of the U.S National Biosolids Repository, 
maintained at the Biodesign Institute at Arizona State University in the laboratory 
of Dr. Halden. During the 10-year period between sample acquisition and 
analysis, samples were stored at -20
o
C. Along with the NSSS samples, soil-
biosolids mixtures from an outdoor mesocosm study conducted in Baltimore, 
Maryland were also analyzed as a part of this study to experimentally determine 
the half-lives of the extended list of PPCPs. Details about the design of the 
mesocosm studies have been provided previously (Walters et al., 2010). 
3.2.2 COMPOSITE SAMPLE PREPARATION 
Of the 113 NSSS samples three were excluded from analysis as the containers 
were broken or compromised (McClellan and Halden 2010). Five groups were 
created with the remaining 110 samples, by weighing out approximately one g of 
dry weight from each sample and pooling it to obtain five composite samples each 
containing solids from between 21 and 24 individual samples. A split sample of 
composite 1 was prepared to serve as blind duplicate. All procedural steps were 
identical to those described previously for the initial mega composite study 
(McClellan and Halden 2010; Appendix A). 
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3.2.3 SAMPLE ANALYSIS 
Samples were analyzed by AXYS Analytical Services (2045 Mills Road West, 
Sydney, British Columbia, V8L 358) according to AXYS Method MLA – 075, a 
modification of the USEPA Method 1694. All analytes were separated by liquid 
chromatography and detected by tandem mass spectrometry. Analytes were 
quantified using isotope dilution technique or internal standard quantification with 
linear regression calibration. More detailed information on the analysis method is 
available in Appendices A and B. 
3.2.4 QUALITY ASSURANCE 
Before sample analyses were performed, several tests were carried out to ensure 
system and laboratory performance. A verification of calibration accuracy was 
performed using calibration standard solution with native and labeled analytes. 
The retention times of both the native and labeled compounds were required to be 
within ± 15 s of the respective retention times determined during initial 
calibration. Throughout the analysis precision and recovery were ensured. Lab 
blanks were analyzed prior to each sample analysis. Analysis of duplicate samples 
was performed by the lab for each batch consisting of seven to 20 samples. In 
addition to these, a blind duplicate was included in the sample set to evaluate 
analysis precision according to the following formula.  
  Equation 1 
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3.2.5 REPRODUCIBILITY OF RESULTS 
To gauge the integrity of the samples and efficiency of the analytical method, a 
statistical comparison was carried out between the present and previous datasets 
obtained for composites created from the same archived individual biosolids 
samples. Data from the study by McClellan and Halden (2010) and from the 
present study were compared statistically using a paired t-test approach and 
scatter-plot correlation analysis. 
3.2.6 MODELING OF POREWATER AND EQUILIBRIUM SOIL 
CONCENTRATION 
In order to inform environmental risk assessments for the compounds newly 
detected in biosolids, the soil concentrations following land application were 
calculated following a previously established approach (McClellan and Halden 
2010). Calculations took into account a soil-biosolids mixing ratio of 25:1. Bulk 
densities of soil and biosolids used in these calculations were assumed to be 1.3 g 
cm
-3
 and 1.6 g cm
-3
 respectively, and an average soil moisture content of 22% 
(v/v) was assumed as reported earlier by others (De Lannoy et al 2006). Organic 
carbon fractions of soil and biosolids were assumed to equal 0.4 (Causarano et al 
2008; USEPA 2007). Calculations involved the two equations below: 
    Equation 2 
  Equation 3 
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, where m is the dry mass in kg m
-3
 of the solids, C is the concentration in μg kg-1, 
ρ is the density in kg m-3 and fporewater and fOC are the dimensionless fractions, 
respectively, of the pore-water and organic carbon in the soil/biosolids mixture, 
respectively. 
3.2.7 DRUG USAGE AND ECOTOXICITY DATA 
Information on drug sales and uses were obtained from Internet sources 
(http://www.rxlist.com) and from the IMS Health database (2009). Ecotoxicity 
and half-life data were predicted using the PBT Profiler software provided online 
by the U.S EPA as described previously (McClellan and Halden 2010).  
 
3.2.8 MODELING OF ANNUAL LOADING TO AGRICULTURAL SOIL 
Annual loading of PPCPs to agricultural soils was calculated for a biosolids 
production rate of 7.2 million dry tons per year, of which 55% is land applied 
(NEBRA 2007) using a previously established approach (McClellan and Halden 
2010). 
3.2.9 EXPERIMENTAL CALCULATION OF HALF-LIFE 
As a part of this study, archived mesocosm samples that contained soil:biosolids 
mixtures were analyzed using the same analytical procedure described previously 
(Walters et al 2010) in order to calculate the half-lives of the sequestered 
compounds.  
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3.3 RESULTS 
3.3.1 DATA QUALITY ASSURANCE 
No detections above the method detection limit were observed in the lab blanks 
for any of the analytes; hence, measured concentrations of all analytes were 
accepted. An On-going Precision and Recovery (OPR) procedure was carried out 
for each target analyte as part of the Quality Assurance/Quality Control (QA/QC) 
protocol. A reference matrix containing known background levels of target 
analytes was spiked with an aliquot of spiking solution while the test samples 
were spiked with surrogate standards. The recovery range obtained from the test 
samples was compared with the reference matrix recovery to establish method 
detection limits and the analyte’s recovery rate. The average recovery rate for a 
subset of 26 compounds that were quantified using internal standards was 103% 
with recoveries ranging from 47-357%. Individual recoveries for all these 
compounds were noted to be within the method’s lower and upper control limits 
with the notable exception of desmethyldiltiazem (357%) whose recovery 
exceeded the method’s upper control limit range of 350%. The values reported for 
this compound thus may represent an over-estimation (Table 4). Recovery rates 
for two compounds were close to the method’s lower control limit, amlodipine 
(47 vs. 45-130%) and alprazolam (73 vs. 70-130%). A significant analytical 
cross-interference was seen between hydrocodone and codeine compounds. An 
algebraic correction was performed for both compounds that enabled detection 
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and correction of false positive occurrences. Values for hydrocodone represent 
approximate concentrations with the interferences taken into account.   
Duplicate analyses revealed a 15% relative percent difference (RPD) for all 
compounds detected consistently in each sample and its corresponding duplicate.  
 
Table 4. Results for 26 PPCPs monitored in five composite samples representing 94 U.S. 
wastewater treatment plants. Compounds observed inconsistently are marked with an 
asterisk (*) and the number of positive detections (n<5) is shown in parentheses. 
# Compound 
MDL  
μg kg-1 
Mean ± Std. Dev. 
μg kg-1 
Recovery 
% 
Use 
1 
10-Hydroxy-
amitriptyline 
0.4 14.4 ± 5.7 97.4 Metabolite 
2 Amitriptyline 0.6 275.4 ±92.8 78.8 Antidepressant 
3 Amlodipine * 4.2 ND (n=3) 47 Ca2+ Channel blocker 
4 Alprazolam* 0.7 ND (n=1) 72.9 Anxiolytic 
5 Atenolol* 1.7 ND (n=1) 94.9 β Blocker 
6 Atorvastatin* 1.4 ND (n=4) 79.7 Antilipidemic 
7 Benzoylecgonine* 0.3 ND (n=2) 92.1 Metabolite 
8 Benztropine 0.5 2.9 ± 0.1 101 Anticholinergic 
9 Cocaine 0.1 3.6 ± 3 97.6 Illicit drug 
10 DEET 0.6 7.4 ± 2.8 112 Insect repellant 
11 Desmethyl-Diltiazem 0.3 7.4 ± 6.1 357 Metabolite 
12 Furosemide* 104 ND (n=2) 92.6 Diuretic 
13 Glyburide* 15.6 ND (n=2) 104 Antidiabetic 
14 Hydrocodone* 4.5 ND (n=4) 83.8 Narcotic analgesic 
15 Metoprolol 4.5 24.5 ± 10.1 93.4 β Blocker 
16 Norfluoxetine 2 42 ± 25.1 100 Metabolite 
17 Norverapamil 0.3 458 ± 169.4 82.7 Metabolite 
18 Oxycodone* 1.2 ND (n=3) 108 Narcotic analgesic 
19 Paroxetine 7.1 61.6 ± 21.7 105 Anti-depressant 
20 Promethazine 0.6 22 ± 6.2 108 Antihistamine 
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21 Propoxyphene 1.2 50 ± 23.2 88.7 Narcotic analgesic 
22 Propranolol 2.5 107.4 ± 36 91.2 β-Blocker 
23 Sertraline 0.5 458 ± 168.3 74 Anti-depressant 
24 Triamterene 0.5 430.4 ± 139.9 81.2 Diuretic 
25 Valsartan* 9.2 ND (n=4) 107 Antihypertensive 
26 Verapamil 0.3 551.4 ± 226.2 92.2 Ca2+ Channel blocker 
*More comprehensive information on each compound is available in Appendix B. 
3.3.2 STUDY REPRESENTATIVENESS AND SAMPLE INTEGRITY 
The results of this study are conservative with respect to the concentration of 
analytes in biosolids from the perspective of storage time, as prolonged storage of 
samples may have allowed for degradation of labile compounds and sample 
pooling may have diluted the concentrations of some analytes to levels below the 
detection limit.  
 
Figure 4. Rank order of mean concentrations of 26 previously unmonitored 
PPCPs that were detected for the first time in composites of 110 U.S biosolids 
samples from the 2001 NSSS. Error bars depict ± one standard deviation (n=5), 
and asterisks (*) indicate compounds that were detected inconsistently. 
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3.3.3 OCCURRENCE OF PPCPS IN BIOSOLIDS  
Of the 120 pharmaceuticals tested for, 59 compounds were detected in at least one 
composite sample (Refer to Figure 4). The mean concentration of the sum of all 
PPCPs detected in the five composite samples was approximately 58.7 ± 19.8 
mg/kg. Four compounds previously reported to occur in the ppm range in these 
samples were detected again at similar levels; these included triclocarban, 
triclosan, ciprofloxacin and ofloxacin. Combined, these four analytes contributed 
about 85% of the total mass of all PPCPs detected.  
 
Figure 5. Rank order of mean concentrations of 59 PPCPs that were detected in 
composites of 110 U.S biosolids samples archived from the 2001 NSSS. Error 
bars depict ± one standard deviation (n=5), and compounds marked with (*) 
indicate inconsistent detection. 
Overall, 26 unreported pharmaceuticals were detected in at least one of the 
composite samples (Figure 4; Table 5). In the following section these compounds 
have been grouped as major and minor contaminants based on the detected 
concentrations and frequency of detection in the samples.  
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Table 5. List of 26 PPCPs detected as part of this analytical study. The number of 
positive occurrences in the five samples analyzed are marked beside the mean 
concentrations; for compounds that were inconsistently detected the maximum 
concentration is reported. The rank of each compound is based on the number of 
prescriptions dispensed for the year 2009 (IMS Health, 2009). The half-life and 
EC50 values were estimated using PBT Profiler software. Structure and chemical 
properties of each compound were taken from the Royal Society of Chemistry 
database. 
Compound 
10-hydroxy-amitriptyline 
CAS: 1159-82-6 
logKow: 2.66 
logDow: 1.50 
Half-life: N.A  
Soil loading: 32-80 kg yr-1 
EC50: N.A 
Amitriptyline 
 
CAS: 50-48-6 
logKow: 4.92 
logDow: 2.65 
Half-life: 120 d-1 
Soil loading: 570-1402 kg 
yr-1 
EC50: 500 μg L
-1 
Rank: 143 
Amlodipine * 
 
CAS: 88150-42-9 
logKow: 3.0 
logDow: 1.50 
Half-life:75 d-1  
Soil loading: 113-205 kg 
yr-1 
EC50: 45 μg L
-1 
Rank: 15 
Alprazolam* 
 
CAS: 28981-97-7 
logKow: 2.12 
logDow: 1.92 
Half-life: 75 d-1  
Soil loading: 6 kg yr-1 
EC50: 10
4 μg L-1 
Rank: 39 
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Atenolol* 
 
CAS: 29122-68-7 
logKow: 0.16 
logDow: -1.76 
Half-life: 75 d-1  
Soil loading: 36.6 kg yr-1 
EC50: 8.1 x 10
3 μg L-1 
Rank: 53 
Atorvastatin* 
 
CAS: 134523-00-5 
logKow: 3.85 
logDow: 0.74 
Half-life: N.A  
Soil loading: 16-25 kg yr-1 
EC50: 10
4 μg L-1 
Rank: 2 
Benzoylecgonine* 
 
CAS: 519-09-5 
logKow: -1.32 
logDow: -0.24 
Half-life: 30 d-1  
Soil loading: 4 kg yr-1 
EC50: 6.5 x 10
5 μg L-1 
Benztropine 
 
CAS: 86-13-5 
logKow: 4.28 
logDow: 1.21 
Half-life: 75 d-1  
Soil loading: 11-12 kg 
yr-1 
EC50: 48 μg L
-1 
Rank: - 
Cocaine 
CAS: 50-36-2 
logKow: 2.30 
logDow: 1.51 
Half-life: 75 d-1  
Soil loading: 7-36 kg yr-1 
EC50: 740 μg L
-1 
DEET 
 
CAS: 134-62-3 
logKow: 2.18 
logDow: 2.42 
Half-life: 75 d-1  
Soil loading: 19-45 kg yr-1 
EC50: 91 μg L
-1 
Desmethyl-Diltiazem 
CAS: 86408-45-9 
logKow: 2.58 
logDow: 2.07 
Half-life: N.A 
Soil loading: 8-69 kg yr-1 
EC50: N.A 
Furosemide* 
 
CAS: 54-31-9 
logKow: 2.03 
logDow: -0.82 
Half-life:120 d-1  
Soil loading: 356-483 kg 
yr-1 
EC50: 1400 μg L
-1 
Rank: 98 
Glyburide* Hydrocodone* Metoprolol Norfluoxetine 
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CAS: 10238-21-8 
logKow: 4.79 
logDow: 1.14 
Half-life: 360 d-1  
Soil loading: 23-82 kg yr-1 
EC50: 2 μg L
-1 
Rank: 149 
 
CAS: 126-29-1 
logKow: 2.16 
logDow: 0.68 
Half-life: N.A 
Soil loading: 24-86 kg yr-1 
EC50: 730 μg L
-1 
Rank: 1 
CAS: 51384-51-1 
logKow: 1.88 
logDow: 0.68 
Half-life: 75 d-1  
Soil loading: 46-150 kg 
yr-1 
EC50: 1400 μg L
-1 
Rank: 170 
 
CAS: 83891-03-6 
logKow: 4.18 
logDow: 2.12 
Half-life: N.A 
Soil loading: 8-329 kg 
yr-1 
EC50: 300 μg L
-1 
Norverapamil 
CAS: 67018-85-3 
logKow: 4.59 
logDow: 1.35 
Half-life: N.A 
Soil loading: 499-2336 kg 
yr-1 
EC50: N.A 
Oxycodone* 
 
CAS: 76-42-6 
logKow: 0.66 
logDow: 1.21 
MDL: 1.2 μg kg-1 
Mean ± Std. dev: nd (n=3) 
Recovery: 108 % 
Half-life: 360 d-1  
Soil loading: 43-622 kg yr-
1 
EC50: 5400 μg L
-1 
Rank: 33 
Paroxetine  
 
CAS: 61869-08-7 
logKow: 2.57 
logDow: 1.48 
Half-life: N.A 
Soil loading: 122-356 kg 
yr-1 
EC50: 140 μg L
-1 
Rank: 127 
Promethazine 
 
CAS: 60-87-7 
logKow: 4.81 
logDow: 3.40 
Half-life: 120 d-1  
Soil loading: 60-117  kg 
yr-1 
EC50: 34 μg L
-1 
Rank: 113 
Propoxyphene Propranolol Sertraline Triamterene 
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CAS: 469-62-5 
logKow: 4.18 
logDow: 2.32 
Half-life: 120 d-1  
Soil loading: 64-304 kg 
yr-1 
EC50: 15 μg L
-1 
Rank: 79 
 
CAS: 525-66-6 
logKow: 3.48 
logDow: 0.79 
Half-life: 30 d-1  
Soil loading: 231-578 kg 
yr-1 
EC50: 360 μg L
-1 
Rank: - 
 
CAS: 79617-96-2 
logKow: 5.29 
logDow: 3.04 
Half-life: N.A 
Soil loading: 883-2519 
kg yr-1 
EC50: 4.3 x 10
4 μg L-1 
Rank: 28 
 
CAS: 396-01-0 
logKow: 0.98 
logDow: 1.12 
Half-life: 75 d-1  
Soil loading: 1030-2309 
kg yr-1 
EC50: 4600 μg L
-1 
Rank: 106 
Valsartan* 
 
CAS: 137862-53-4 
logKow: 3.65 
logDow: 0.20 
Half-life: N.A  
Soil loading: 95-254 kg 
yr-1 
EC50: N.A 
Rank: 30 
Verapamil 
 
CAS: 52-53-9 
logKow: 3.79 
logDow: 2.46 
Half-life: 360 d-1  
Soil loading: 586-2665 kg 
yr-1 
EC50: 1.3 μg L
-1 
Rank: 198 
 
The majority of these compounds have not been reported previously in the NSSS 
nor were they detected in U.S biosolids samples, although several were detected 
previously in sludges from other parts of the world (Ternes et al 2007).  
 
3.3.4 REPRODUCIBILITY OF RESULTS  
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When comparing the present list of detected analytes to those reported previously 
by McClellan and Halden (2010), 30 analytes were found to be common to both 
studies, whereas eight compounds that had been detected previously were 
uniformly not detected in any of the samples during the present study. A 
comparison of mean concentrations of compounds detected in this study and those 
reported in 2010 (Figure 6) shows good agreement between the two. A paired t-
test conducted on both the log-transformed and original datasets showed the 
results to be statistically indistinguishable at the 99% confidence level. Mean 
concentrations of compounds were within a factor of about 1.3 between 
previously obtained and current data. 
 
Figure 6. Log-log scatterplot comparing mean concentrations from the present 
study to those reported previously for 30 compounds commonly detected. Both 
datasets represent results obtained from analysis of composites created two years 
apart from the same group of archived samples.  
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3.3.5 EXPERIMENTAL HALF-LIFE DETERMINATION 
Analytical results from the mesocosm samples revealed consistent first-order loss 
rates for four compounds, namely amitriptyline, paroxetine, propranolol and 
sertraline (Figure 7).  
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Figure 7. Decreasing concentrations of compounds plotted as natural logarithms 
vs. time (common x-axis). Compound structures were obtained from the database 
of the Royal Society of Chemistry. 
Compound-specific half-lives in biosolids-amended soils were calculated by 
fitting the experimental data to first-order kinetics, yielding values ranging from 
533 to 866 days (Table 6). 
 
 
Table 6. Half-lives determined experimentally in mesocosm experiments versus, 
shown in parentheses, the corresponding values estimated using the PBT Profiler 
of the U.S. EPA. 
Compound Calculated half-
life, days
-1
 
Predicted loading to U.S. soils, 
kg yr
-1
 
Amitriptyline 533 (120) 570 - 1402 
Paroxetine 770 (NA) 122 - 356 
Propranolol 866 (30) 231 - 578 
Sertraline 630 (NA) 883- 2519 
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3.4 DISCUSSION 
3.4.1 STUDY LIMITATIONS 
For the purpose of this study, 110 archived biosolids samples were pooled 
together to create five megacomposite samples. This technique effectively 
reduced the number of samples required to estimate the mean concentrations of 
drug residues in U.S. sludges. This approach is economically attractive but does 
not allow for extrapolating obtained results to individual treatment plants and 
operating conditions. Compounds not detected in this study may still occur at 
detectable concentrations in some of the individual samples from specific plants 
because the pooling of samples can dilute out low-level analytes that occur 
infrequently. Nevertheless, this technique was found to be suitable for identifying 
contaminants and their average concentrations in a large sample set in an 
economical and efficient fashion.  
It is important to recall that separate batches of composite samples were prepared 
and analyzed for both studies. Since labile compounds are eliminated during the 
wastewater treatment process, more refractory compounds tend to persist and 
accumulate in sludge. Such compounds are fairly resilient to environmental stress 
and tend to have extended half-lives in the sequestering matrix. The closeness of 
results between the two analysis campaigns (Figure 6) indicates that the sample 
integrity had been preserved over the years during storage and that good 
reproducibility can be achieved with the composite sample approach.  
3.4.2 NEWLY REPORTED PPCPS IN BIOSOLIDS 
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3.4.2.1 MAJOR CONTAMINANTS 
Calcium channel blockers and metabolites. Two parent compounds 
(amlodipine, verapamil) and two metabolites (norverapamil, desmethyldiltiazem) 
were detected in the biosolids samples. Amlodipine was detected at a maximum 
concentration of 51.7 μg kg-1 and verapamil was detected in all samples at a mean 
concentration of 551.4 ± 226.2 μg kg-1. The metabolites norverapamil and 
desmethyldiltiazem were uniformly detected in all samples at mean 
concentrations of 360.2 ± 169.4 μg kg-1 and 7.4 ± 6.1 μg kg-1, respectively. 
Calcium channel blockers have been reported previously in the µg L
-1
 to ng L
-1
 
range in wastewater effluents and in surface waters (Batt et al 2008; Nagarnaik et 
al 2010). All four compounds lacked data for establishing a comparative analysis, 
as they have not been reported in any major study. 
Antidepressants and metabolites. Three antidepressants (paroxetine, sertraline, 
amitriptyline) and two metabolites (10-hydroxy-amitriptyline, norfluoxetine) were 
detected as well. Paroxetine, sertraline and norfluoxetine were uniformly detected 
in all samples at mean concentrations of, respectively, 61.6 ± 21.7, 458 ± 168.3 
and 41.6 ± 25.1 μg kg-1. Paroxetine, sertraline, norverapamil and 10-hydroxy-
amitriptyline have been reported to occur in surface waters across the U.S in the 
ng L
-1
 range (Schultz and Furlong 2008; Wu et al 2009, Batt et al 2008) and 
interestingly, in the low to high µg L
-1
 range in fish tissues (Chu and Metcalfe 
2007; Ramirez et al 2009). Radjenovic et al (2009) reported paroxetine in 
biosolids at a concentration of 40.7 ± 13.0 μg kg-1, similar to the mean 
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concentration reported here. While in this study the highest detected concentration 
of sertraline was 636 μg kg-1, Barron (2009) reported levels as high as 22 mg kg-1 
in biosolids samples from Sweden and Norway; they also reported values for 
amitriptyline and its metabolite similar to those presented here (275.4 ± 92.8 and 
14.4 ± 5.7 μg kg-1, repectively). The latter two compounds have been detected in 
aquatic matrices (Kasprzyk-Hordern et al 2008; Batt et al 2008).  
Diuretics. Triamterene was uniformly detected in all samples at a mean 
concentration of 430.4 ± 139.9 μg kg-1, whereas furosemide was found at a 
maximum level of 122 μg kg-1. Furosemide has been reported to have a highly 
variable removal range (8-54%) during wastewater treatment including nearly 
zero removal in winter (Castiglioni et al 2006).  The most recent study conducted 
on the behavior of pharmaceuticals during conventional wastewater treatment 
reported a maximum detected value of 75 μg kg-1 in biosolids and calculated a 
removal range of 30-80% for furosemide (Jelic et al 2011). There were no reports 
on the occurrence of triamterene in biosolids.  
β-Blockers. Metoprolol and propranolol were uniformly detected in all samples at 
mean concentrations of 24.5 ± 10.1 and 107.4 ± 36 μg kg-1 , respectively, whereas 
atenolol was detected at a maximum concentration of 9.25 μg kg-1. Metoprolol 
has been observed previously in biosolids at 35 ± 7 μg kg-1 (Barron 2009). Apart 
from this, there have been several published studies conducted on metoprolol and 
its presence in aquatic matrices. These studies indicated a range of removal 
efficiencies exhibited by WWTPs, from 0 – 80% (Jelic et al 2011). Propranolol 
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also has been detected in aquatic and solid matrices alike. Levels in the low ppb 
range were reported in WWTP process streams and in surface waters (Bendz et al 
2005; Scheurer et al 2010).  Concentrations found in Norwegian biosolids (101 ±3 
μg kg-1) mirrored the range reported here, whereas Radjenović et al 2009 
observed Propranol at lower concentrations of 26.2 ± 10.7 μg kg-1 in sludge 
samples from Spain. Atenolol has been detected previously in sludge at levels 
similar to those reported here (Barron 2009; Jelic et al 2011); it is one of  the most 
frequently tested for pharmaceuticals in leachates from biosolids (Lapen et al 
2008; Topp et al 2008).  
(Narcotic) Analgesics. Propoxyphene was detected in all samples at mean 
concentration of 49.9 ± 23.2 μg kg-1, whereas hydrocodone and oxycodone were 
detected at maximum concentrations of 21.7 μg kg-1 and 157 μg kg-1, respectively. 
Historically, all three drugs have been associated with abuse, and are frequently 
detected by U.S forensics labs (Daughton 2011). Both hydrocodone and 
oxycodone have been detected previously in surface waters and wastewater 
streams, most frequently in the low to high ppb range in surface waters of the U.S. 
and other nations (Hummel et al 2006; Batt et al 2008; Chiaia et al 2008; Phillips 
et al 2010) although no published studies were found with regards to analyses of 
solid matrices.  
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3.4.2.2 MINOR CONTAMINANTS 
MISCELLANEOUS COMPOUNDS  
DEET (N,N-diethyl-meta-toluamide) has been reported in aquatic matrices 
including surface waters (Kolpin et al 2002), landfill leachates (Eggen et al 2010), 
WWTP streams (Trenholm et al 2006; Bartelt-Hunt et al 2009) and in U.S 
groundwater (Barnes et al 2004). In the present study, DEET was uniformly 
detected in all biosolids samples at a mean concentration of 7.4 ± 2.8 μg kg-1.  
Howard et al (2010) listed promethazine and benztropine as high production 
volume (HPV) pharmaceuticals that have not been detected in the environment. In 
the present study both pharmaceuticals were uniformly detected in all samples at 
mean concentration of 21.9 ± 6.2 μg kg-1 and 2.9 ± 0.1 μg kg-1. 
The maximum detected concentrations of valsartan, glyburide, alprazolam, and 
atorvastatin were 64.1, 20.6,
 
1.56, and 6.2 μg kg-1. Atorvastatin has previously 
been detected in WWTP process streams and in biosolids at concentrations of 20 
– 46 ppb (Miao and Metcalfe 2003; Batt et al 2008; Jelic et al 2011). 
Cocaine and metabolite. Testing of environmental matrices (most commonly 
aquatic) for the presence of illicit drugs has recently gained impetus. The presence 
of cocaine and benzoylecgonine (metabolite)  has been reported in wastewater 
streams and surface waters across Europe (Castiglioni et al 2006; Ventura et al 
2007; Kasprzyk-Hordern et al 2008; Postigo et al 2010; Gonzáles-Mariño et al 
2010) and in U.S WWTP influent (Chiaia et al 2008). Here, we report uniform 
detection of cocaine in all biosolids composites analyzed. To our knowledge, this 
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is the first study to report the presence of cocaine in U.S biosolids; however, the 
mean concentration found was low at 3.6 ± 3 μg kg-1. Benzoylecgonine was 
detected at even lower levels, never exceeding 1.05 μg kg-1 
These results provide some of the first documented occurrences of select 
compounds in biosolids. For a more detailed analysis of worldwide occurrences of 
these and other seldom monitored compounds, readers should refer to Appendix 
C. 
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Figure 8. Predicted porewater concentration range (A) and equilibirum 
concentration range in soils-biosolids mixtures (B) for 26 PPCPs at 
environmentally relevant pH range 7-9. Concentration range for each compound 
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has been printed with corresponding mean values in paranthesis. Compounds 
marked with (*) were inconsistently detected. 
 
Figure 9. Predicted EC50 values for 22 compounds. Values for some compounds 
could not be calculated and may represent potential hazard to aquatic organisms.  
Compounds marked with (*) indicate inconsistent detection. 
3.4.3 SOIL/POREWATER EQUILIBRIA AND HALF-LIFE CALCULATION  
In order to determine if the compounds detected in biosolids potentially pose a 
threat to aquatic organisms, toxicity values were estimated using the PBT Profiler 
of the U.S. EPA. From a comparison of the modeled porewater concentrations for 
these compounds with predicted toxicity data (Fig. 7 (A.) vs. Fig. 8), it was 
concluded that the presence of these compounds in biosolids at the detected 
concentrations posed no threat to aquatic organisms in nearby surface waters. The 
EC50 values were at least one order of magnitude higher than the porewater 
concentrations calculated for these compounds. Since we followed EPA-
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recommended soil-biosolids mixing ratio of 25:1 when predicting analyte levels 
in surface water impacted by porewater leaching, there is a possibility that these 
compounds may be toxic to organisms in situations where mixing ratios may 
differ (e.g. applications in forests). 
Results from the PBT Profiler were also significant when estimating the 
persistence of these compounds in the environment. It was noted that all 
compounds had half-life values of  ≥30 days. Upon correlating these findings with 
their respective log KOW values, it was found that the tendency to accumulate in 
solids was in part due to the high hydrophobicity of some compounds, whereas 
forces other than hydrophobic interactions are presumed to govern partitioning of 
compounds such as cocaine and oxycodone. In mesocosm studies containing soil-
biosolids mixtures, Walters et al (2010) experimentally showed that the half-lives 
of compounds applied to soils in the form of biosolids were much greater than 
half-lives predicted by fate models and laboratory studies using addition of neat 
chemicals to soils. By leveraging the archived soil/biosolids samples from the 
aforementioned mesocosm study, we were able to compute half-lives for four 
compounds whose loss over time followed first-order kinetics. These analytes 
were amitriptyline, paroxetine, propranolol and sertraline (Figure 7).   
3.4.4 RISK ASSESSMENTS AND DATA GAPS  
Of all PPCPs detected in this study, three groups of compounds that have been 
noted for their pharmacodynamic effects on humans were found to occur 
uniformly in the high ppb range either as parent compounds or as metabolites. 
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These were antidepressants (n =5), β-blockers (n =2) and narcotic analgesics (n 
=3). Owing to an absence of terrestrial field studies, experimental and modeled 
values had to be relied upon as best estimates for potential hazards caused by the 
presence of PPCPs in the environment. Studies have demonstrated the ability of 
lipophillic compounds to undergo bioaccumulation and biomagnification within 
terrestrial food chains (Higgins et al 2007; Kinney et al 2008). Given the 
magnitude of annual loading reported in this study and the lack of 
bioaccumulation studies for these newly detected PPCPs, further work in this area 
appears to be warranted.  
Of particular significance were the calculated half-lives for the compounds 
amitriptyline, paroxetine, propranolol and sertraline (Table 5).  While values were 
absent for paroxetine and sertraline, the experimental t1/2 value was noted to 
exceed the predicted t1/2 by at least a factor of 4 for amitriptyline and by 29 for 
propranolol. Correlating the experimental t1/2 value with the individual annual 
loading rate proved crucial in gauging the magnitude of potential exposure to 
these pharmaceuticals.  
Apart from this, sequestered compounds tend to occur as mixtures and not 
discreetly in biosolids and soils. Thus, greater emphasis should be placed on the 
effects of pharmaceutical mixtures on soil-dwelling organisms. Although effort 
has gone into studying the effects of antibiotics on soil microorganisms and the 
development of resistant species, the environmental pressures exerted by these 
compounds especially in solid matrices have not been thoroughly investigated. 
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This lack of information prevents the completion of a comprehensive risk 
assessment for all compounds. 
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Chapter 4: CONCLUSION 
The here presented research study aims at highlighting the in silico and 
experimental approaches that allow for assessing the risks posed by compounds 
that are sequestered in biosolids samples. Conclusions for the two independently 
performed studies are as follows. 
4.1 STUDY I 
The expansion, validation and application of mathematical modeling performed in 
this work provided new estimates on the concentration range of ten sterols and 
four hormones in environmental compartments. A hazard assessment revealed 
that the hormones E1, E2 and E3 feature high migratory potentials in soil, with E1 
and E3 projected to yield the highest porewater concentrations, and EE2 posing a 
potential threat to fathead minnows (P. promelas). This work underscored the 
utility of modeling for assessing the potential impact of endocrine disrupting 
compounds sequestered in biosolids during wastewater treatment. 
4.2 STUDY II 
Twenty-six compounds were newly detected in archived biosolids samples, and 
are predicted to enter terrestrial environments in the U.S. through biosolids 
application at a combined rate of 5-15 tons yr
-1
. The majority of these compounds 
have not been extensively investigated with regards to occurrence and effects in 
the environment and exposure pathways to humans. This study further 
demonstrated that consistent results can be obtained when analyzing archived 
biosolids from national sampling campaigns by using a mega composite 
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approach. This implies that long-term storage of samples in the freezer at 
temperatures of -20 degrees Celsius or less does not significantly impact the 
analytes examined here, and that the mixing of composite samples from thawed 
slurries, although being challenging, can be performed such that consistent results 
are obtained. This finding is noteworthy as this mega composite sampling 
approach could help to dramatically reduce the cost of environmental monitoring 
on the regional and national scale. While it has been established that mean 
concentrations of several PPCPs in U.S biosolids have remained fairly constant 
over the years, the detection of a set of new compounds in biosolids warrants 
analysis of more recent biosolids samples in order to establish a trend, with 
regards to both their occurrence and concentrations detected.  
4.3 FUTURE RESEARCH NEEDS 
Toxicity data that have been published in the peer-reviewed literature are helpful 
resources when assessing the risks posed by xenobiotics in the environment. 
Although field data are preferred and more credible for use in risk analyses, 
predictive data from the PBT Profiler of the U.S. EPA can serve as a substitute. A 
similar situation was experienced with both research studies presented here and 
predictive data were used in place of experimental data owing to incomplete 
information, non-uniformity of test species or the complete lack of half-life data.  
Over the years since its inception, results from the U.S. EPA supervised TNSSS 
have played a vital role in changing the perception associated with beneficial 
reuse of biosolids. These results have also contributed to source control and 
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exposure management of chemicals sequestered in biosolids. However, a major 
improvement to this program would be to improve the frequency at which it is 
conducted, so that the scientific community can keep track of the ever increasing 
number of chemicals that are discharged into sewers by the public and industries.    
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The 2001 NSSS aimed at analyzing sewage sludge that was intended for land 
disposal for dioxin and dioxin-like compounds. During a 7 week sampling period 
between February and March 2001, 94 wastewater treatment plants were 
randomly selected from a pool of 174 facilities that had been sampled during the 
1989 NSSS. These WWTPs were representative of 32 states and the District of 
Columbia. Eighty-nine facilities were noted to have a single system for treating 
and processing their sludge and hence one final sludge sample was collected from 
each of these facilities. Five facilities had two systems for treating their sludge 
material and therefore one sample per treatment process was taken. A total of 99 
product samples were collected from the 94 wastewater treatment plants and for 
quality control testing and field duplicates were collected from 15% of treatment 
plants. The total number of samples that were analyzed was 113. 
Composite sludges were divided into two aliquots of up to 1 g dry solids, and 
adjusted for pH with phosphate buffer and ammonium hydroxide, respectively, 
prior to acid and base extraction. Acidic and base fractions were spiked with 
stable isotope-labeled surrogate standards of the target analytes. Both fractions 
were sonicated and extracted three times with a phosphate buffer/acetonitrile 
solution for the 
acid fraction, and with an ammonium hydroxide/acetonitrile solution for the base 
fraction. Then, both fractions were concentrated to remove acetonitrile and re-
diluted with reagent water. For acid extraction Na4EDTA was added for 
stabilization. Both the acid fraction and the base fraction were cleaned using a 
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solid-phase extraction (SPE) hydrophilic-lipophilic balance (HLB) 20ccm 
cartridges containing 1 g of resin. The acid fraction was washed with reagent 
water to remove EDTA, and the analytes were eluted 
with methanol. In addition, triclocarban and triclosan were eluted with a mixture 
of equal parts of acetone and methanol. The base fraction was eluted with 
methanol followed by 2% formic acid. After extraction, both fractions were 
concentrated under a nitrogen atmosphere and reconstituted in methanol. Internal 
standards were added to both fractions just prior to analysis. 
For the purpose of compound detection, the 120 analytes were divided into five 
groups. All analytes were separated by liquid chromatography and detected by 
tandem mass spectrometry. Groups 1,2,3 and 5 were extracted under acidic 
conditions at pH 2. Groups 1,2, 4 and 5 were analyzed in positive electrospray 
ionization (ESI) mode, with Group 2 being specific to tetracyclines. Group 3 was 
analyzed in negative ESI mode. Group 4 was extracted under basic conditions at 
pH 10 and analyzed in positive ESI mode. 
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APPENDIX B 
TABLE 7 
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 List of 120 analytes that were detected for using the MLA-075 method. 
Compounds printed in bold indicate new analytes. 
List 1 
(Acid 
extraction, 
positive 
ESI) 
Acetaminophen 
Ampicillin
1
 
Azithromycin 
Caffeine  
Carbadox 
Carbamazepine 
Cefotaxime 
Ciprofloxacin 
Clarithromycin 
Clinafloxacin 
Cloxacillin  
Dehydroni-
fedipine 
Digoxigenin 
Digoxin 
Diltiazem 
1,7-Dimethyl-
xanthine 
Diphen-
hydramine 
Enrofloxacin 
Erythromycin 
Flumequine 
Fluoxetine 
 
Lincomycin 
Lomefloxacin 
Miconazole 
Norfloxacin 
Norgestimate 
Ofloxacin 
Ormetoprim 
 
Oxacillin 
Oxolinic acid 
Penicillin G 
Penicillin V 
Roxithromycin 
Sarafloxacin 
Sulfachloro-
pyridazine 
 
Sulfadiazine 
Sulfadimethoxi
ne 
Sulfamerazine 
Sulfamethazine 
Sulfamethizole 
Sulfamethoxaz
ole 
Sulfanilamide 
 
Sulfathiazole 
Thiabendazole 
Trimethoprim 
Tylosin 
Virginiamycin 
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List 2 
(Tetracycli
nes, 
positive 
ESI) 
Anhydrochlortetracycline (ACTC) 
Anhydrotetracycline (ATC) 
Chlortetracycline (CTC) 
Demeclocycline  
Doxycycline 
4-Epianhydrochlortetracycline 
(EACTC) 
4-Epianhydrotetracycline (EATC) 
4-Epichlortetracycline (ECTC) 
4-Epioxytetracycline (EOTC) 
4-Epitetracycline (ETC) 
Isochlortetracycline (ICTC) 
Minocycline 
Oxytetracycline (OTC) 
Tetracycline (TC) 
List 3 
(Acid 
extraction, 
negative 
ESI) 
Bisphenol A 
Furosemide 
Gemfibrozil 
Glipizide 
Glyburide 
Hydrochlorothia
zide 
2-hydroxy-
ibuprofen 
 
Ibuprofen 
Naproxen 
Triclocarban 
Triclosan 
Warfarin 
List 4 
(Base 
extraction, 
positive 
ESI) 
Albuterol 
Amphetamine 
Atenolol 
Atorvastatin 
Cimetidine 
Clonidine 
Codeine 
Cotinine 
Enalapril 
Hydrocodone 
Metformin 
Oxycodone 
Ranitidine 
Triamterene 
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List 5 
(Acid 
Extraction, 
positive 
ESI) 
Alprazolam 
Amitriptyline 
Amlodipine 
Benzoylecgonine 
Benztropine 
Betamethasone 
Cocaine 
 
DEET (N,N-
diethyl-m-
toluamide) 
Desmethyl-
diltiazem 
Diazepam 
Fluocinonide 
Fluticasone 
propionate 
Hydrocortisone 
10-hydroxy-
amitriptyline 
 
Meprobamate 
Methyl-
prednisolone 
Metoprolol 
Norfluoxetine 
Norverapamil 
Paroxetine 
Prednisolone 
Prednisone 
Promethazine 
Propoxy-phene 
Propranolol 
Sertraline 
Simvastatin 
Theophylline 
Trenbolone 
Trenbolone-
acetate 
Valsartan 
Verapamil 
 
1
 Due to instability accuracy of Ampicillin data is unknown. 
75 
 
APPENDIX C 
TABLE 8 
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World-wide occurrences of the newly detected 26 PPCPs in the present study 
 
# 
 
Compound class 
Detection matrix  
Source Wastewater Surface 
water 
Biosolid
s Influen
t 
Effluen
t 
1 Calcium channel blockers 
a.  Amlodipine √    Nagarnaik et al., 2010 
b
.  
Verapamil  √   Batt et al., 2008 
 
2 Diuretics      
a. Furosemide √ √ √  Castiglioni et al., 2006 
 √ √  √ Jelic et al., 2011 
b
.  
Triamterene  √ √  Batt et al., 2008 
 
3 Selective serotonin reuptake inhibitors 
a.  Paroxetine  √   Batt et al., 2008 
  √ √  Schultz and Furlong 2008 
   √  Wu et al., 2009 
  √   Radjenović et al., 2009 
  b
. 
Sertraline  √ √  Schultz and Furlong 2008 
    √ Barron, 2009 
  √   Batt et al., 2008 
 
4 Metabolites 
a. Norverapamil   √  Batt et al., 2008 
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b
. 
Norfluoxetine   √  Schultz and Furlong 
2008; Kolpin et al., 2002 
      
c. 10-hydroxy-
amitriptyline 
  √  Batt et al., 2008 
d
. 
Desmethyldiltiaze
m 
 √ √  Batt et al., 2008 
e. Benzoylecgonine   √  Kasprzyk-Hordern et 
al.,2008 
 √ √   Quintana et al., 2010 
 √ √ √  Ventura et al., 2007; 
Postigo et al., 2010 
 √    Field et al., 2008 
 √ √   Castiglioni et al., 2006 
 
5 Tricyclic antidepressants 
a. Amitriptyline   √  Kasprzyk-Hordern et 
al.,2008 
 
 
   √ Batt et al., 2008 
 
6 Drugs of abuse 
       
      
      
      
a. Cocaine √ √   Ventura et al., 2007;  
Quintana et al., 2010 
    √ Kasprzyk-Hordern et al., 
2008; Postigo 2010; 
Quintana 2010 
 √    Field et al., 2008 
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7 Beta blockers      
a. Metoprolol √ √   Ternes et al., 2007; 
Scheurer et al., 2010 
 √ √ √  Jelic et al., 2011 
  √ √  Hernando et al., 2005 
     √ Barron, 2009 
b
. 
Propranolol √ √   Bendz et al., 2005; 
Maurer et al., 2007; 
Scheurer et al., 2010 
    √ Radjenović et al., 2009; 
Barron, 2009 
  √ √  Batt et al., 2008 
c.  Atenolol  √ √  Batt et al., 2008 
8 Analgesics 
a. Oxycodone √    Ternes et al., 2006; 
Chiaia et al., 2008 
  √   Phillips et al., 2010 
b
. 
Propoxyphene  √   Batt et al., 2008 
c. Hydrocodone  √ √  Batt et al., 2008 
 √    Chiaia et al., 2008 
 
 
9 Ungrouped chemicals 
a. DEET √ √   Bartelt-Hunt et al., 2008 
   √  Trenholm et al., 2006 
b
. 
Promethazine  √   Batt et al., 2008 
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c. Valsartan  √ √  Batt et al., 2008 
d
.  
Glyburide  √ √  Batt et al., 2008 
e.  Alprazolam  √ √  Batt et al., 2008 
f. Benztropine      
g
. 
Atorvastatin √ √  √ Jelic et al., 2011 
  √   Metcalfe et al., 2003; 
Batt et al., 2008 
*This is not a comprehensive list. 
